BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 12117916)

  • 1. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature.
    Kawahara K; Tsukano H; Watanabe H; Lindner B; Matsuura M
    Infect Immun; 2002 Aug; 70(8):4092-8. PubMed ID: 12117916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in lipid A structure in the pathogenic yersiniae.
    Rebeil R; Ernst RK; Gowen BB; Miller SI; Hinnebusch BJ
    Mol Microbiol; 2004 Jun; 52(5):1363-73. PubMed ID: 15165239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica.
    Hajjar AM; Ernst RK; Fortuno ES; Brasfield AS; Yam CS; Newlon LA; Kollmann TR; Miller SI; Wilson CB
    PLoS Pathog; 2012; 8(10):e1002963. PubMed ID: 23071439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the lipopolysaccharide of Yersinia pestis.
    Prior JL; Hitchen PG; Williamson DE; Reason AJ; Morris HR; Dell A; Wren BW; Titball RW
    Microb Pathog; 2001 Feb; 30(2):49-57. PubMed ID: 11162185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early evolutionary loss of the lipid A modifying enzyme PagP resulting in innate immune evasion in
    Chandler CE; Harberts EM; Pelletier MR; Thaipisuttikul I; Jones JW; Hajjar AM; Sahl JW; Goodlett DR; Pride AC; Rasko DA; Trent MS; Bishop RE; Ernst RK
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22984-22991. PubMed ID: 32868431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural diversity and endotoxic activity of the lipopolysaccharide of Yersinia pestis.
    Dentovskaya SV; Bakhteeva IV; Titareva GM; Shaikhutdinova RZ; Kondakova AN; Bystrova OV; Lindner B; Knirel YA; Anisimov AP
    Biochemistry (Mosc); 2008 Feb; 73(2):192-9. PubMed ID: 18298376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and biological characterization of highly purified hepta-acyl lipid A present in the lipopolysaccharide of the Salmonella enterica sv. Minnesota Re deep rough mutant strain R595.
    Janusch H; Brecker L; Lindner B; Alexander C; Gronow S; Heine H; Ulmer AJ; Rietschel ET; Zähringer U
    J Endotoxin Res; 2002; 8(5):343-56. PubMed ID: 12537693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory effects of Yersinia pestis lipopolysaccharides on human macrophages.
    Matsuura M; Takahashi H; Watanabe H; Saito S; Kawahara K
    Clin Vaccine Immunol; 2010 Jan; 17(1):49-55. PubMed ID: 19889939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature-dependent variations and intraspecies diversity of the structure of the lipopolysaccharide of Yersinia pestis.
    Knirel YA; Lindner B; Vinogradov EV; Kocharova NA; Senchenkova SN; Shaikhutdinova RZ; Dentovskaya SV; Fursova NK; Bakhteeva IV; Titareva GM; Balakhonov SV; Holst O; Gremyakova TA; Pier GB; Anisimov AP
    Biochemistry; 2005 Feb; 44(5):1731-43. PubMed ID: 15683257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct biological activity of lipopolysaccharides with different lipid A acylation status from mutant strains of Yersinia pestis and some members of genus Psychrobacter.
    Korneev KV; Kondakova AN; Arbatsky NP; Novototskaya-Vlasova KA; Rivkina EM; Anisimov AP; Kruglov AA; Kuprash DV; Nedospasov SA; Knirel YA; Drutskaya MS
    Biochemistry (Mosc); 2014 Dec; 79(12):1333-8. PubMed ID: 25716726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Yersinia pestis EV 76 lypopolysaccharides with different levels of toxicity on dynamics of TNF-alpha and INF-gamma synthesis by human monocytes].
    Sokolova EP; Demidova GV; Ziuzina VP; Alekseeva LP; Bespalova IA; Tynianova VI
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (4):59-64. PubMed ID: 20799400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and biological characterisation of a novel tetra-acyl lipid A from Escherichia coli F515 lipopolysaccharide acting as endotoxin antagonist in human monocytes.
    Zähringer U; Salvetzki R; Wagner F; Lindner B; Ulmer AJ
    J Endotoxin Res; 2001; 7(2):133-46. PubMed ID: 11521094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of monosaccharide lipid A analogues in human monocytic cells as agonists or antagonists of bacterial lipopolysaccharide.
    Matsuura M; Kiso M; Hasegawa A
    Infect Immun; 1999 Dec; 67(12):6286-92. PubMed ID: 10569739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.
    Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
    mBio; 2017 May; 8(3):. PubMed ID: 28487429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of late acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation.
    Rebeil R; Ernst RK; Jarrett CO; Adams KN; Miller SI; Hinnebusch BJ
    J Bacteriol; 2006 Feb; 188(4):1381-8. PubMed ID: 16452420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yersinia pestis evades TLR4-dependent induction of IL-12(p40)2 by dendritic cells and subsequent cell migration.
    Robinson RT; Khader SA; Locksley RM; Lien E; Smiley ST; Cooper AM
    J Immunol; 2008 Oct; 181(8):5560-7. PubMed ID: 18832714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis.
    Novem V; Shui G; Wang D; Bendt AK; Sim SH; Liu Y; Thong TW; Sivalingam SP; Ooi EE; Wenk MR; Tan G
    Clin Vaccine Immunol; 2009 Oct; 16(10):1420-8. PubMed ID: 19692625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.
    Sun W; Six D; Kuang X; Roland KL; Raetz CR; Curtiss R
    Vaccine; 2011 Apr; 29(16):2986-98. PubMed ID: 21320544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of lipid A acylation pattern on membrane permeability and innate immune stimulation.
    Li Y; Wang Z; Chen J; Ernst RK; Wang X
    Mar Drugs; 2013 Aug; 11(9):3197-208. PubMed ID: 24065161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxicity and cytokine-inducing activity of lipopolysaccharide of virulent Yersinia pestis 231 strain].
    Sokolova EP; Demidova GV; Ziuzina VP; Borodina TN; Bespalova IA; Alekseeva LP; Tynianova VI
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):20-6. PubMed ID: 22308722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.